Bristol-Myers Surrenders Anti-HIV Drug Patent In Thailand
By Marius Meland ( January 16, 2004, 12:00 AM EST) -- Bristol-Myers Squibb has given up a long-standing patent dispute with Thai AIDS activists and agreed to surrender its patent for the anti-retroviral drug didanosine (ddI) in tablet form....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.